Island Pharmaceuticals Limited Share Price
Equities
ILA
AU0000138869
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.056 AUD | 0.00% | 0.00% | -41.05% |
16/04 | Island Pharmaceuticals Reports Positive Data from Dose Study of Dengue Medication | MT |
25/02 | Island Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 6.37M 9.64M 532M |
---|---|---|---|---|---|
Net income 2024 * | -2M -3.02M -167M | Net income 2025 * | -2M -3.02M -167M | EV / Sales 2024 * | - |
Net cash position 2024 * | 600K 907K 50.05M | Net cash position 2025 * | 3.1M 4.69M 259M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.87
x | P/E ratio 2025 * |
-3.5
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 41.26% |
Current month | +5.66% | ||
1 month | -13.85% | ||
3 months | -34.12% | ||
6 months | -23.29% | ||
Current year | -41.05% |
Managers | Title | Age | Since |
---|---|---|---|
David Foster
FOU | Founder | - | 25/20/25 |
Jane Lowe
IRC | Investor Relations Contact | - | - |
Stephanie Vipond
SEC | Corporate Secretary | - | 01/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Al Hansen
BRD | Director/Board Member | 69 | 01/20/01 |
Paul MacLeman
CHM | Chairman | 58 | 25/20/25 |
David Brookes
BRD | Director/Board Member | 63 | 01/20/01 |
Date | Price | Change | Volume |
---|---|---|---|
06/24/06 | 0.056 | 0.00% | 27 164 |
03/24/03 | 0.056 | 0.00% | 435,635 |
02/24/02 | 0.056 | +5.66% | 98,570 |
01/24/01 | 0.053 | 0.00% | 43,757 |
30/24/30 | 0.053 | -5.36% | 67,587 |
Delayed Quote Australian S.E., May 06, 2024 at 06:20 am IST
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-41.05% | 4.21M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |
- Stock Market
- Equities
- ILA Stock